TNXP EBITDA Growth
Tonix Pharmaceuticals Holding Corp · EBITDA Growth
TNXP EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-98.32%period ending
TNXP TTM EBITDA YoY % (-46.05% → -98.32%)
Year-over-year change
High-resolution chart · PNG
TNXP ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -98.317% | |
| -12.5188% | |
| 3.5691% | |
| 25.7721% | |
| 44.8793% | |
| -37.4936% | |
| -12.6799% | |
| -11.8771% | |
| -20.9872% | |
| 18.0775% | |
| -3.1221% | |
| -8.8279% | |
| -22.2546% | |
| -17.1312% | |
| -18.0297% | |
| -34.8791% | |
| -32.9585% | |
| -53.2218% | |
| -82.8698% | |
| -89.1367% | |
| -92.3842% | |
| -114.4707% | |
| -75.2795% | |
| -52.2698% | |
| -50.2406% | |
| -16.5031% | |
| -9.6467% | |
| -14.74% | |
| -3.727% | |
| -10.8497% | |
| -24.0637% | |
| -4.6039% | |
| 1.618% | |
| 22.8308% | |
| 45.4262% | |
| 48.334% | |
| 50.6544% | |
| 42.7989% | |
| 19.1746% | |
| -2.3733% | |
| -33.0365% | |
| -62.7315% | |
| -73.7907% | |
| -95.3941% | |
| -110.2439% | |
| -128.8553% | |
| -154.0705% | |
| -211.6372% | |
| -209.765% | |
| -151.7595% | |
| -131.7741% | |
| 11.0292% | |
| 20.8229% | |
| 4.6088% | |
| 10.5959% | |
| -327.9439% | |
| -739.355% | |
| -1,017.0105% | |
| -29,499.5543% | |
| -12,133.5456% | |
| -6,006.6974% | |
| -1,926.4898% | |
| 42.5795% | |
| 49.5922% | |
| 54.6465% | |
| -12.5125% | |
| -46.0538% |